Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors.
Journal of translational medicine | 2016-04-19 | PMID 27095081
Schreuer Max, Meersseman Geert, Van Den Herrewegen Sari and 9 more
Genes: BRAF
